- Home
- ETV vs CLDX Comparison
ETV vs CLDX Comparison
Compare ETV & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETV
- CLDX
- Stock Information
- Founded
- ETV 2005
- CLDX N/A
- Country
- ETV United States
- CLDX United States
- Employees
- ETV N/A
- CLDX N/A
- Industry
- ETV Investment Managers
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ETV Finance
- CLDX Health Care
- Exchange
- ETV Nasdaq
- CLDX Nasdaq
- Market Cap
- ETV 1.6B
- CLDX 1.3B
- IPO Year
- ETV N/A
- CLDX 2008
- Fundamental
- Price
- ETV $13.21
- CLDX $18.15
- Analyst Decision
- ETV
- CLDX Buy
- Analyst Count
- ETV 0
- CLDX 8
- Target Price
- ETV N/A
- CLDX $54.29
- AVG Volume (30 Days)
- ETV 252.5K
- CLDX 749.8K
- Earning Date
- ETV 01-01-0001
- CLDX 05-05-2025
- Dividend Yield
- ETV 8.75%
- CLDX N/A
- EPS Growth
- ETV N/A
- CLDX N/A
- EPS
- ETV N/A
- CLDX N/A
- Revenue
- ETV N/A
- CLDX $7,020,000.00
- Revenue This Year
- ETV N/A
- CLDX N/A
- Revenue Next Year
- ETV N/A
- CLDX $27.01
- P/E Ratio
- ETV N/A
- CLDX N/A
- Revenue Growth
- ETV N/A
- CLDX 1.99
- 52 Week Low
- ETV $11.05
- CLDX $17.63
- 52 Week High
- ETV $13.50
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- ETV 34.77
- CLDX 34.76
- Support Level
- ETV $13.22
- CLDX $19.48
- Resistance Level
- ETV $13.65
- CLDX $20.38
- Average True Range (ATR)
- ETV 0.16
- CLDX 1.04
- MACD
- ETV 0.02
- CLDX -0.02
- Stochastic Oscillator
- ETV 32.31
- CLDX 12.32
About ETV Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.